PremiumThe FlyLargest borrow rate increases among liquid names PacBio price target lowered to $1.25 from $2 at Piper Sandler PacBio board: Independent investigation concludes allegations unsubstantiated PremiumThe FlyPac Bio options imply 14.4% move in share price post-earnings Largest borrow rate increases among liquid names Is PACB a Buy, Before Earnings? PremiumThe FlyLargest borrow rate increases among liquid names PacBio to be technology partner to DAC’s NADR project Cathie Wood’s ARK Investment bought 143.5K shares of PacBio today 
